Your browser doesn't support javascript.
loading
Urinary EGF and MCP-1 and risk of CKD after cardiac surgery.
Menez, Steven; Ju, Wenjun; Menon, Rajasree; Moledina, Dennis G; Thiessen Philbrook, Heather; McArthur, Eric; Jia, Yaqi; Obeid, Wassim; Mansour, Sherry G; Koyner, Jay L; Shlipak, Michael G; Coca, Steven G; Garg, Amit X; Bomback, Andrew S; Kellum, John A; Kretzler, Matthias; Parikh, Chirag R.
Afiliación
  • Menez S; Division of Nephrology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Ju W; Division of Nephrology, Department of Medicine, and Department of Computational Medicine and Bioinformatics, University of Michigan, Ann Arbor, Michigan, USA.
  • Menon R; Division of Nephrology, Department of Medicine, and Department of Computational Medicine and Bioinformatics, University of Michigan, Ann Arbor, Michigan, USA.
  • Moledina DG; Section of Nephrology and.
  • Thiessen Philbrook H; Clinical and Translational Research Accelerator, Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut, USA.
  • McArthur E; Division of Nephrology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Jia Y; ICES, Ontario, Canada.
  • Obeid W; Division of Nephrology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Mansour SG; Division of Nephrology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Koyner JL; Section of Nephrology and.
  • Shlipak MG; Clinical and Translational Research Accelerator, Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut, USA.
  • Coca SG; Section of Nephrology, Department of Medicine, University of Chicago, Chicago, Illinois, USA.
  • Garg AX; Kidney Health Research Collaborative and Division of General Internal Medicine, San Francisco Veterans Affairs Medical Center, University of California San Francisco, San Francisco, California, USA.
  • Bomback AS; Division of Nephrology, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
  • Kellum JA; ICES, Ontario, Canada.
  • Kretzler M; Division of Nephrology, Department of Medicine, and.
  • Parikh CR; Department of Epidemiology and Biostatistics, Schulich School of Medicine & Dentistry, Western University, London, Ontario, Canada.
JCI Insight ; 6(11)2021 06 08.
Article en En | MEDLINE | ID: mdl-33974569
BACKGROUNDAssessment of chronic kidney disease (CKD) risk after acute kidney injury (AKI) is based on limited markers primarily reflecting glomerular function. We evaluated markers of cell integrity (EGF) and inflammation (monocyte chemoattractant protein-1, MCP-1) for predicting long-term kidney outcomes after cardiac surgery.METHODSWe measured EGF and MCP-1 in postoperative urine samples from 865 adults who underwent cardiac surgery at 2 sites in Canada and the United States and assessed EGF and MCP-1's associations with the composite outcome of CKD incidence or progression. We used single-cell RNA-Seq (scRNA-Seq) of AKI patient biopsies to perform transcriptomic analysis of programs corregulated with the associated genes.RESULTSOver a median (IQR) follow-up of 5.8 (4.2-7.1) years, 266 (30.8%) patients developed the composite CKD outcome. Postoperatively, higher levels of urinary EGF were protective and higher levels of MCP-1 were associated with the composite CKD outcome (adjusted HR 0.83, 95% CI 0.73-0.95 and 1.10, 95% CI 1.00-1.21, respectively). Intrarenal scRNA-Seq transcriptomes in patients with AKI-defined cell populations revealed concordant changes in EGF and MCP-1 levels and underlying molecular processes associated with loss of EGF expression and gain of CCL2 (encoding MCP-1) expression.CONCLUSIONUrinary EGF and MCP-1 were each independently associated with CKD after cardiac surgery. These markers may serve as noninvasive indicators of tubular damage, supported by tissue transcriptomes, and provide an opportunity for novel interventions in cardiac surgery.TRIAL REGISTRATIONClinicalTrials.gov NCT00774137.FUNDINGThe NIH funded the TRIBE-AKI Consortium and Kidney Precision Medicine Project. Yale O'Brien Kidney Center, American Heart Association, Patterson Trust Fund, Dr. Adam Linton Chair in Kidney Health Analytics, Canadian Institutes of Health Research, ICES, Ontario Ministry of Health and Long-Term Care, Academic Medical Organization of Southwestern Ontario, Schulich School of Medicine & Dentistry, Western University, Lawson Health Research Institute, Chan Zuckerberg Initiative Human Cell Atlas Kidney Seed Network.
Asunto(s)
Palabras clave

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Complicaciones Posoperatorias / Quimiocina CCL2 / Factor de Crecimiento Epidérmico / Insuficiencia Renal Crónica / Lesión Renal Aguda / Procedimientos Quirúrgicos Cardíacos Tipo de estudio: Etiology_studies / Incidence_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: JCI Insight Año: 2021 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Complicaciones Posoperatorias / Quimiocina CCL2 / Factor de Crecimiento Epidérmico / Insuficiencia Renal Crónica / Lesión Renal Aguda / Procedimientos Quirúrgicos Cardíacos Tipo de estudio: Etiology_studies / Incidence_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: JCI Insight Año: 2021 Tipo del documento: Article